Biomerica, Inc. (BMRA)

NASDAQ: BMRA · Real-Time Price · USD
0.355
-0.017 (-4.57%)
Nov 4, 2024, 4:00 PM EST - Market closed
-4.57%
Market Cap 5.97M
Revenue (ttm) 5.51M
Net Income (ttm) -6.16M
Shares Out 16.82M
EPS (ttm) -0.37
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 92,847
Open 0.376
Previous Close 0.372
Day's Range 0.350 - 0.376
52-Week Range 0.240 - 2.130
Beta -1.14
Analysts n/a
Price Target n/a
Earnings Date Oct 15, 2024

About BMRA

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company’s diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist i... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1971
Employees 64
Stock Exchange NASDAQ
Ticker Symbol BMRA
Full Company Profile

Financial Performance

In 2024, Biomerica's revenue was $5.42 million, an increase of 1.42% compared to the previous year's $5.34 million. Losses were -$5.98 million, -16.27% less than in 2023.

Financial Statements

News

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

IRVINE, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, is excited to announce a major enhancement to its inFoods® ...

5 days ago - GlobeNewsWire

Biomerica Reports First Quarter Fiscal 2025 Financial Results

IRVINE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial res...

19 days ago - GlobeNewsWire

The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer

- 10-Minute At-Home PSA Test for Early Detection of Prostate Cancer - First order already shipped to Saudi Arabia - Prostate Cancer is the Second Most Common Cancer in Men Globally IRVINE, Calif., Sep...

2 months ago - GlobeNewsWire

Biomerica Reports Fiscal 2024 Year End Results

IRVINE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) today reported its financial results for the fiscal year ended May 31, 2024. The Company achieved a modest increase in ...

2 months ago - GlobeNewsWire

Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers

IRVINE, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, is proud to announce a major enhancement to its inFoods® IBS system, a...

4 months ago - GlobeNewsWire

Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024

IRVINE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products, today announced the initiati...

6 months ago - GlobeNewsWire

Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement

IRVINE, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Biomerica Inc. (Nasdaq: BMRA), is proud to announce a multi-year exclusive distribution agreement with one of the UAE's most substantial healthcare c...

6 months ago - GlobeNewsWire

Biomerica provides update on inFoods® IBS expansion

- Expansion into new offices within current major groups, including Northeast and Ohio; Expansion into new major group in Texas.

7 months ago - GlobeNewsWire

Biomerica Reports Third Quarter 2024 Financial Results

IRVINE, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial re...

7 months ago - GlobeNewsWire

Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference

IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company at the forefront of innovative gastroenterology solutions, proudly announces that data fr...

7 months ago - GlobeNewsWire

Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

Mr. Huff was the Former CEO of LabCorp Diagnostics and joins with significant executive experience and a proven track record in medical diagnostics and healthcare Mr. Huff was the Former CEO of LabCor...

9 months ago - GlobeNewsWire

Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

IRVINE, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appointment ...

10 months ago - GlobeNewsWire

Biomerica Reports Second Quarter 2024 Financial Results

IRVINE, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial res...

10 months ago - GlobeNewsWire

Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population

IRVINE, Calif., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic products, today announced it has received U.S. Food a...

11 months ago - GlobeNewsWire

Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

IRVINE, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products today announced that it will participate in the 14th An...

1 year ago - GlobeNewsWire

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

IRVINE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products today announced that several new Gastrointestinal (GI) ...

1 year ago - GlobeNewsWire

REPEAT - Biomerica Reports First Quarter 2024 Financial Results

Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024 vs the first fiscal quarter of 2023 Company believes current cash position, forecasted revenue growth and corporate...

1 year ago - GlobeNewsWire

Biomerica Reports First Quarter 2024 Financial Results

Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024 vs the first fiscal quarter of 2023 Company believes current cash position, forecasted revenue growth and corporate...

1 year ago - GlobeNewsWire

Dubai Government Grants Insurance Reimbursement for Biomerica's EZ Detect™ Colorectal Disease Screening Test

Simple 2 minute at-home test detects an early warning sign of colorectal cancer, the third most common cancer worldwide Simple 2 minute at-home test detects an early warning sign of colorectal cancer,...

1 year ago - GlobeNewsWire

Diagnostics Industry Leader Jack Kenny Joins Biomerica's Board of Directors

NEWPORT BEACH, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appoin...

1 year ago - GlobeNewsWire

Biomerica Reports Fiscal 2023 Year End Results

IRVINE, Calif., Aug. 25, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its fiscal 2023 financial results.

1 year ago - GlobeNewsWire

CVS Health to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Disease Screening Test

IRVINE, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that CVS Pharmacy has begun in-store sales rollout of the Company's EZ Detect™ colorect...

1 year ago - GlobeNewsWire

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients

IRVINE, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative diagnostic solutions, announced that the China National Intel...

1 year ago - GlobeNewsWire

inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology

NEWPORT BEACH, Calif., May 18, 2023 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, announced a significant adv...

1 year ago - GlobeNewsWire

Biomerica's inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).

IRVINE, Calif., April 17, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic products, is pleased to announce that inFoods® IBS, ...

1 year ago - GlobeNewsWire